halothane has been researched along with bay-k-8644 in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 17 (89.47) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamantidis, MM; Adnet, PJ; Haudecoeur, G; Imbenotte, M; Krivosic-Horber, RM; Reyford, H | 1 |
| Baum, VC | 1 |
| Bollen, BA; McKlveen, RE; Stevenson, JA | 1 |
| Brooks, HL; Kampine, JP; Kenny, D; Pelc, LR; Schmeling, WT; Warltier, DC | 1 |
| Adamantidis, MM; Adnet, PJ; Cordonnier, C; Haudecoeur, G; Imbenotte, M; Krivosic-Horber, RM; Reyford, GH | 1 |
| Adamantidis, MM; Adnet, PJ; Cordonnier, C; Haudecoeur, G; Krivosic-Horber, RM; Reyford, H | 1 |
| Holland, M; Lee, JC; McGrath, CJ; Ward, CW; Williams, JH | 1 |
| Davy, KP; Holland, M; Lee, JC; Ward, CW; Williams, JH | 1 |
| Adamantidis, M; Adnet, P; Haudecoeur, G; Krivosic-Horber, R | 1 |
| Hettrick, DA; Pagel, PS; Warltier, DC | 1 |
| Böhm, M; Böhm, S; Erdmann, E; Müller-Ehmsen, J; Reichart, B; Schmidt, U; Schwinger, RH; Uberfuhr, P; von Meyer, L | 1 |
| Baum, VC; Klitzner, TS | 1 |
| Pagel, PS; Warltier, DC | 1 |
| Fujita, S; Namba, H; Namiki, A; Notsuki, E; Tsuchida, H; Yamakage, M | 1 |
| Denborough, MA; Foster, PS | 1 |
| Böhm, M; Böhm, S; Erdmann, E; Kreuzer, E; Meyer, L; Reichart, B; Schmidt, U; Schwinger, RH; Uberfuhr, P | 1 |
| Kanaya, N; Kawana, S; Kimura, H; Matsumoto, M; Miyamoto, A; Namiki, A; Ohshika, H; Tsuchida, H | 1 |
| Kanaya, N; Kawana, S; Miyamoto, A; Namiki, A; Ohshika, H; Tsuchida, H | 1 |
| Jamali, NZ; Lucchinetti, E; Shafiq, SA; Siddiqui, MA; Zaugg, M | 1 |
19 other study(ies) available for halothane and bay-k-8644
| Article | Year |
|---|---|
Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium Channel Blockers; Calcium Channels; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Synergism; Halothane; Humans; Isoflurane; Malignant Hyperthermia; Muscle Contraction; Receptors, Nicotinic | 1992 |
Will the calcium channel agonist BAY K8644 inhibit halothane-induced impairment of calcium current?
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Drug Interactions; Guinea Pigs; Halothane; Heart Ventricles; Myocardium; Sarcolemma | 1992 |
Halothane relaxes preconstricted small and medium isolated porcine coronary artery segments more than isoflurane.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Coronary Vessels; Halothane; In Vitro Techniques; Isoflurane; Kinetics; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Chloride; Swine; Time Factors | 1992 |
Calcium channel modulation of alpha 1- and alpha 2-adrenergic pressor responses in conscious and anesthetized dogs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Anesthesia, Inhalation; Animals; Azepines; Blood Pressure; Calcium Channel Agonists; Dogs; Female; Halothane; Isoflurane; Male; Phenylephrine | 1990 |
Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Caffeine; Disease Susceptibility; Drug Synergism; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction | 1990 |
Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Biopsy; Calcium Channel Blockers; Calcium Channels; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Isotonic Solutions; Malignant Hyperthermia; Muscle Contraction; Muscles; Nifedipine; Receptors, Nicotinic; Verapamil | 1991 |
BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Caffeine; Calcium; Halothane; Malignant Hyperthermia; Muscle Contraction; Muscles; Nifedipine; Swine | 1991 |
Effects of BAY K 8644, nifedipine, and low Ca2+ on halothane and caffeine potentiation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Caffeine; Calcium; Drug Synergism; Halothane; In Vitro Techniques; Muscle Contraction; Muscles; Nifedipine; Swine | 1991 |
[Effects of BAY K 8644, a slow calcium channel agonist, on muscle contraction induced by halothane in sensitive subjects with malignant hyperthermia].
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction | 1989 |
Left ventricular mechanical consequences of dihydropyridine calcium channel modulation in conscious and anesthetized chronically instrumented dogs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Anesthetics; Animals; Autonomic Nerve Block; Autonomic Nervous System; Calcium Channels; Consciousness; Diastole; Dihydropyridines; Dogs; Drug Interactions; Halothane; Hemodynamics; Isoflurane; Myocardial Contraction; Nifedipine; Systole; Ventricular Function, Left | 1994 |
Influence of halothane on the effect of cAMP-dependent and cAMP-independent positive inotropic agents in human myocardium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adult; Aged; Calcium; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Female; Halothane; Humans; In Vitro Techniques; Male; Middle Aged; Milrinone; Myocardial Contraction; Norepinephrine; Pyridones | 1994 |
Effect of calcium channel agonist (BAY K8644) on volatile anesthetic-mediated depression in neonatal rabbit papillary muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Animals, Newborn; Halothane; Isoflurane; Papillary Muscles; Rabbits; Volatilization | 1993 |
Mechanical consequences of calcium channel modulation during volatile anesthetic-induced left ventricular systolic and diastolic dysfunction.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthetics; Animals; Calcium; Calcium Channels; Diastole; Dogs; Halothane; Isoflurane; Nifedipine; Systole; Ventricular Dysfunction, Left | 1994 |
Effects of halothane and isoflurane on cytosolic calcium ion concentrations and contraction in the vascular smooth muscle of the rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Caffeine; Calcium; Calcium Channels; Cytosol; Dose-Response Relationship, Drug; Halothane; Isoflurane; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Rats; Rats, Sprague-Dawley; Ryanodine; Sarcoplasmic Reticulum | 1993 |
The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Diltiazem; Halothane; Malignant Hyperthermia; Muscle Contraction; Muscles; Nifedipine; Potassium Chloride; Sarcoplasmic Reticulum; Swine; Verapamil | 1993 |
Evidence for an interaction of halothane with the L-type Ca2+ channel in human myocardium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Binding Sites; Calcium Channels; Drug Interactions; Female; Halothane; Heart; Humans; Isradipine; Male; Middle Aged; Myocardial Contraction; Myocardium | 1993 |
Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthetics, Inhalation; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Halothane; Heart Ventricles; Isradipine; Myocardial Contraction; Myocardium; Nifedipine; Rats; Rats, Wistar; Sarcolemma; Verapamil | 1998 |
Comparative myocardial depression of sevoflurane, isoflurane, and halothane in cultured neonatal rat ventricular myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthetics, Inhalation; Animals; Animals, Newborn; Calcium Channel Agonists; Cells, Cultured; Halothane; Heart; Heart Rate; Isoflurane; Methyl Ethers; Myocardium; Rats; Rats, Wistar; Sevoflurane | 1998 |
Norepinephrine-induced apoptosis is inhibited in adult rat ventricular myocytes exposed to volatile anesthetics.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthetics, Inhalation; Animals; Apoptosis; Calcium Channel Agonists; Cells, Cultured; DNA Fragmentation; Halothane; Heart Ventricles; In Situ Nick-End Labeling; Isoflurane; Male; Microscopy, Electron; Norepinephrine; Rats; Rats, Sprague-Dawley; Signal Transduction | 2000 |